Atai Life Sciences Long-Term Investments 2020-2024 | ATAI
Atai Life Sciences long-term investments from 2020 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
| Atai Life Sciences Annual Long-Term Investments (Millions of US $) |
|
|---|---|
| 2023 | $92 |
| 2022 | $7 |
| 2021 | $28 |
| 2020 | $8 |
| 2019 | $23 |
| Atai Life Sciences Quarterly Long-Term Investments (Millions of US $) |
|
|---|---|
| 2024-09-30 | $79 |
| 2024-06-30 | $94 |
| 2024-03-31 | $133 |
| 2023-12-31 | $92 |
| 2023-09-30 | $75 |
| 2023-06-30 | $4 |
| 2023-03-31 | $6 |
| 2022-12-31 | $7 |
| 2022-09-30 | $8 |
| 2022-06-30 | $10 |
| 2022-03-31 | $20 |
| 2021-12-31 | $28 |
| 2021-09-30 | $36 |
| 2021-06-30 | $43 |
| 2021-03-31 | $7 |
| 2020-12-31 | $8 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $23 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.245B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $20.877B | 0.00 |
| Quest Diagnostics (DGX) | United States | $16.876B | 17.10 |
| DaVita (DVA) | United States | $13.632B | 17.63 |
| Encompass Health (EHC) | United States | $9.545B | 22.50 |
| Chemed (CHE) | United States | $8.349B | 25.66 |
| Elanco Animal Health (ELAN) | United States | $5.942B | 14.14 |
| Option Care Health (OPCH) | United States | $4.962B | 23.52 |
| RadNet (RDNT) | United States | $4.431B | 98.13 |
| LifeStance Health (LFST) | United States | $3.057B | 0.00 |
| Amedisys (AMED) | United States | $3.010B | 21.42 |
| Addus HomeCare (ADUS) | United States | $2.427B | 28.48 |
| Astrana Health (ASTH) | United States | $1.978B | 27.05 |
| U.S Physical Therapy (USPH) | United States | $1.337B | 35.14 |
| Pennant (PNTG) | United States | $0.943B | 38.14 |
| Aveanna Healthcare Holdings (AVAH) | United States | $0.899B | 0.00 |
| Bioqual (BIOQ) | United States | $0.058B | 0.00 |
| Daxor (DXR) | United States | $0.041B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| IMAC Holdings (BACK) | United States | $0.003B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |